Background and purpose Flow diverters (FDs) have become one of the primary treatments for intracranial aneurysms (IAs). However, their use in distal IA has been associated with higher complication ...
Patients suffering from malignant brain tumors are burdened with a grim prognosis. The blood brain barrier is considered a primary obstacle in therapeutic drug delivery to the brain. Intra-arterial ...
Correspondence to Dr Gaurav Jindal, Division of Interventional Neuroradiology University of Maryland Medical Center, Baltimore, Maryland, USA ; drjindal{at}gmail.com Background The first pass effect ...
Background Heterogeneity in the infarct growth rate among anterior circulation large vessel occlusion (LVO) strokes has triage and treatment implications. Such data are lacking for basilar artery ...
University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK Correspondence to Dr Saleh Lamin, Queen Elizabeth Hospital, University Hospitals Birmingham NHS ...
Background Futile recanalization—when patients have a successful recanalization but fail to achieve a satisfactory functional outcome— is a common phenomenon of endovascular treatment of acute ...
Correspondence to Dr Julien Dinkel, Department of Radiology, University Hospital Heidelberg, Heidelberg 69120, Germany; julien.dinkel{at}med.uni-heidelberg.de Background Dual-energy CT (DECT) has been ...
11 Department of Radiology and Neurological Surgery, Columbia University, College of Physicians and Surgeons, and Neuroendovascular Service, New York Presbyterian-Columbia, Neurological Institute of ...
1 Department of Medicine, Abington Memorial Hospital, Abington, Pennsylvania, USA 2 Neurosciences Institute, Abington Memorial Hospital, Abington, Pennsylvania, USA Correspondence to Dr Q A Shah, ...
Background Despite its low incidence, basilar artery occlusion (BAO) remains a major therapeutic challenge since severe disability and death occur in about 80% of patients. Specific site of BAO ...
Background Cangrelor is an intravenous P2Y12 inhibitor with rapid onset and fast offset of antiplatelet action. Dose adjusted cangrelor based on platelet function testing is suggested to be ...
4 Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA Correspondence to Dr S L Blackburn, Department of Neurosurgery, University of Florida, P O Box ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback